✦ LIBER ✦

Phase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer

✍ Scribed by Schwartzberg, Lee S.; Badarinath, Suprith; Keaton, Mark R.; Childs, Barrett H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

Combination docetaxel and trastuzumab tr

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

A Randomized Phase II Study of Paclitaxe

✍ Adam Brufsky; Karen Hoelzer; Thaddeus Beck; Robert Whorf; Mark Keaton; Padma Nad 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 441 KB

Trastuzumab plus docetaxel with or witho

✍ A. Wardlev; A. Anton-Torres; X. Pivot; F. Morales-Vasquez; L. Zetina; M. de Fati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

A Phase II Trial of Gemcitabine/Carbopla

✍ Denise A. Yardley; Howard A. Burris III; Lisa Simons; David R. Spigel; F. Anthon 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB

A multicenter phase I–II study of doceta

✍ Tryfonidis, K.; Boukovinas, I.; Xenidis, N.; Christophyllakis, C.; Papakotoulas, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 348 KB